In the present study, we combined AZD-9291 with GDC-0084 to evaluate their regulatory effect on the downstream MEK/ERK and AKT/mTOR signaling pathways of EGFR and to explore the mechanism underlying the inhibition of GBM growth. The gene discussed is MAP2K7; the disease is glioblastoma.